{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:30:06Z","timestamp":1765279806413},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.humpath.2013.02.009","type":"journal-article","created":{"date-parts":[[2013,5,6]],"date-time":"2013-05-06T08:00:18Z","timestamp":1367827218000},"page":"1859-1866","source":"Crossref","is-referenced-by-count":18,"title":["Proton magnetic resonance metabolomic characterization of ovarian serous carcinoma effusions: chemotherapy-related effects and comparison with malignant mesothelioma and breast carcinoma"],"prefix":"10.1016","volume":"44","author":[{"given":"Riyas","family":"Vettukattil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thea Eline","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivi Ann","family":"Fl\u00f8renes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tone F.","family":"Bathen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2011","series-title":"Serous effusions","author":"Davidson","key":"10.1016\/j.humpath.2013.02.009_bb0005"},{"key":"10.1016\/j.humpath.2013.02.009_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1039\/C1AN15605E","article-title":"Modern analytical techniques in metabolomics analysis","volume":"137","author":"Zhang","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/j.humpath.2013.02.009_bb0015","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2013.02.009_bb0020","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jprot.2011.10.027","article-title":"Recent and potential developments of biofluid analyses in metabolomics","volume":"75","author":"Zhang","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.humpath.2013.02.009_bb0025","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1021\/pr200960u","article-title":"Urine metabolic signature of pancreatic ductal adenocarcinoma by (1)h nuclear magnetic resonance: identification, mapping, and evolution","volume":"11","author":"Napoli","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0030","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00216-012-6117-1","article-title":"Serum metabolomics as a novel diagnostic approach for disease: a systematic review","volume":"404","author":"Zhang","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.humpath.2013.02.009_bb0035","doi-asserted-by":"crossref","first-page":"e42926","DOI":"10.1371\/journal.pone.0042926","article-title":"Novel use of proton magnetic resonance spectroscopy (1HMRS) to non-invasively assess placental metabolism","volume":"7","author":"Denison","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2013.02.009_bb0040","doi-asserted-by":"crossref","first-page":"e42330","DOI":"10.1371\/journal.pone.0042330","article-title":"Serum levels of choline-containing compounds are associated with aerobic fitness level: the HUNT-study","volume":"7","author":"Bye","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2013.02.009_bb0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cca.2012.01.026","article-title":"Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography\/mass spectrometry","volume":"413","author":"Zhang","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.humpath.2013.02.009_bb0050","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/pr101050d","article-title":"Diagnosis of early stage ovarian cancer by 1H NMR metabonomics of serum explored by use of a microflow NMR probe","volume":"10","author":"Garcia","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1586\/erm.11.29","article-title":"Ovarian cancer screening and peritoneal carcinomatosis: standards, 'omics' and miRNAs for personalized management","volume":"11","author":"Spiliotis","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.humpath.2013.02.009_bb0060","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1021\/pr200173q","article-title":"Serum 27-nor-5beta-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer","volume":"10","author":"Chen","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0065","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1158\/1078-0432.CCR-10-1434","article-title":"Urine metabolite analysis offers potential early diagnosis of ovarian and breast cancers","volume":"16","author":"Slupsky","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/nbm.1232","article-title":"(1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods","volume":"21","author":"Bala","year":"2008","journal-title":"NMR Biomed"},{"key":"10.1016\/j.humpath.2013.02.009_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jmr.2009.11.012","article-title":"icoshift: A versatile tool for the rapid alignment of 1D NMR spectra","volume":"202","author":"Savorani","year":"2010","journal-title":"J Magn Reson"},{"key":"10.1016\/j.humpath.2013.02.009_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11306-007-0099-6","article-title":"Assessment of PLSDA cross validation","volume":"4","author":"Westerhuis","year":"2008","journal-title":"Metabolomics"},{"key":"10.1016\/j.humpath.2013.02.009_bb0085","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1021\/pr800145j","article-title":"Multilevel data analysis of a crossover designed human nutritional intervention study","volume":"7","author":"van Velzen","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0090","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0022-4804(87)90109-0","article-title":"Mechanisms of malignant ascites production","volume":"42","author":"Garrison","year":"1987","journal-title":"J Surg Res"},{"issue":"Suppl 1","key":"10.1016\/j.humpath.2013.02.009_bb0095","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1002\/mrc.2519","article-title":"Fast targeted multidimensional NMR metabolomics of colorectal cancer","volume":"47","author":"Ludwig","year":"2009","journal-title":"Magn Reson Chem"},{"key":"10.1016\/j.humpath.2013.02.009_bb0100","first-page":"1383","article-title":"Immunohistochemical study of fatty acid synthase in ovarian neoplasms","volume":"7","author":"Alo","year":"2000","journal-title":"Oncol Rep"},{"key":"10.1016\/j.humpath.2013.02.009_bb0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0046-8177(97)90177-5","article-title":"Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival","volume":"28","author":"Gansler","year":"1997","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2013.02.009_bb0110","doi-asserted-by":"crossref","first-page":"285191","DOI":"10.1155\/2010\/285191","article-title":"Expression of fatty acid synthase depends on NAC1 and is associated with recurrent ovarian serous carcinomas","volume":"2010","author":"Ueda","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.humpath.2013.02.009_bb0115","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1158\/0008-5472.CAN-06-3439","article-title":"Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells","volume":"67","author":"Zhou","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0120","first-page":"1189","article-title":"Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer","volume":"56","author":"Pizer","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0125","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.humpath.2013.02.009_bb0130","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/0008-5472.331.65.1","article-title":"Apolipoprotein E is required for cell proliferation and survival in ovarian cancer","volume":"65","author":"Chen","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2013.02.009_bb0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/gyno.2001.6172","article-title":"Prognostic factors of stage IV epithelial ovarian cancer: a multicenter retrospective study","volume":"81","author":"Akahira","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2013.02.009_bb0140","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.1999.17.3.767","article-title":"Natural history of stage IV epithelial ovarian cancer","volume":"17","author":"Bonnefoi","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2013.02.009_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/dc.20280","article-title":"Tumor microenvironment: What can effusions teach us?","volume":"33","author":"Kassis","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.humpath.2013.02.009_bb0150","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.4161\/cc.10.24.18487","article-title":"Energy transfer in \"parasitic\" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.humpath.2013.02.009_bb0155","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1111\/j.1349-7006.2010.01670.x","article-title":"Early reduction of glucose uptake after cisplatin treatment is a marker of cisplatin sensitivity in ovarian cancer","volume":"101","author":"Egawa-Takata","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.humpath.2013.02.009_bb0160","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.bjc.6604523","article-title":"[18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study","volume":"99","author":"Direcks","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.humpath.2013.02.009_bb0165","first-page":"603","article-title":"Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy","volume":"47","author":"Engles","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.humpath.2013.02.009_bb0170","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1158\/0008-5472.CAN-05-2285","article-title":"An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development","volume":"65","author":"Cullinane","year":"2005","journal-title":"Cancer Res"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713000932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817713000932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T14:19:03Z","timestamp":1688221143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817713000932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0046817713000932"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2013.02.009","relation":{},"ISSN":["0046-8177"],"issn-type":[{"type":"print","value":"0046-8177"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}